forty-five days after entry there were no differences between the methylprednisolone and placebo groups in mortality ( respectively , 30 of 50 [ 60 percent ; 95 percent confidence interval , 46 to 74 ] and 31 of 49 [ 63 percent ; 95 percent confidence interval , 49 to 77 ] ; p = 0.74 ) or in the reversal of ards ( 18 of 50 [ 36 percent ] vs. 19 of 49 [ 39 percent ] ; p = 0.77 ) .
C0025815
methylprednisolone
C0035222
ards